<DOC>
	<DOCNO>NCT01305070</DOCNO>
	<brief_summary>Comparison recurrent-restenosis rate 6 month angioplasty in-stent restenoses in-stent reocclusions superficial femoral artery ( SFA ) use either standard balloon ( Admiral Xtreme , Invatec ) paclitaxel-eluting balloon ( In.Pactâ„¢ Admiral , Invatec ) .</brief_summary>
	<brief_title>Standard Balloon Angioplasty Versus Angioplasty With Paclitaxel-eluting Balloon Femoral Artery In-stent Restenosis</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>1 . Age &gt; 21 year old . 2 . Patient must sign informed consent form . 3 . Patient must agree participate study comply followup requirement . 4 . Clinically , patient must Rutherford category 2 4 . Angiographic 5 . Planned angioplasty instent restenoses ( degree stenosis 70100 % ) within SFA . The target lesion must extend beyond stent margin . In case two stenotic region within stented segment , consider separate lesion nonstenotic mildly stenotic ( &lt; 30 % ) segment least 2 cm length . Otherwise , consider single lesion . In case separate lesion , proximal lesion take target lesion ! 6 . The length instent lesion least 1 cm maximally 20 cm ( measurement radiopaque ruler ) . 7 . The degree target lesion stenosis must determine preinterventional duplex ultrasound . 8 . The target lesion region start origin SFA end distally femoropopliteal crossover ( cross SFA medial rim femur PA projection ) . 9 . Patency ( &lt; 50 % stenosis ) popliteal artery least 1 infragenicular artery . General : 1 . Patient currently participate another clinical trial . 2 . Pregnancy pregnancy plan study duration . 3 . Life expectancy less 1 year . 4 . Comorbidities prevent study participation . 5 . Severe coagulation disorder . 6 . Current treatment anticoagulant aspirin , ticlopidine , clopidogrel prasugrel . 7 . Active gastric ulcer gastrointestinal bleeding . 8 . Thrombotic occlusion target vessel within previous 4 week . 9 . Treatment target lesion laser atherectomy device . 10 . Dialysis dependency . 11 . Manifest hyperthyreosis . 12 . Known allergy contrast agent adequately control usual premedication . 13 . Known heparin intolerance . 14 . Known paclitaxel intolerance . Angiographic : 15 . Target lesion extends popliteal artery . 16 . Symptomatic untreated inflow lesion &gt; 50 % ipsilateral iliac artery . Pretreatment iliac stenosis possible . 17 . SFA lesion &gt; 50 % stenosis proximal and/or distal target lesion require treatment . 18 . Target lesion extend beyond stent margin .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Standard balloon angioplasty</keyword>
	<keyword>POBA</keyword>
	<keyword>Angioplasty paclitaxel-eluting balloon</keyword>
	<keyword>Superficial femoral artery</keyword>
</DOC>